New research on tirzepatide, the drug behind Zepbound and Mounjaro, suggests it could significantly lower the risk of major cardiovascular event.
You Might Also Like
Barbara Corcoran shares the number one reason she fires people
The main reason Shark Tank star Barbara Corcoran fires people? Having a bad attitude. On a recent podcast episode of…
3 Min Read
A Popular Fast Food Chain Just Went All-In on MAHA With Its Latest Hire
Steak ’n Shake has appointed its first-ever Make America Healthy Again officer.
0 Min Read
Nike Is Reshaping Its Entire Business. 1,400 Jobs Just Got Cut
The cuts are part of a sweeping overhaul of Nike’s operations, from tech teams to global supply chains, as the…
0 Min Read
The one thing Apple’s new CEO needs to get right on AI
“Apple has a new CEO; he’s a hardware guy.” That quick distillation of Apple’s impending leadership change spread fast across…
5 Min Read